Bernard Charbonnel, MD, is presently Professor of Endocrinology and Metabolic Diseases at the University of Nantes (FRANCE),  Head of the Internal Medicine, Endocrinology and Diabetes Department at the Hôtel Dieu (University Hospital of Nantes).
Among various responsabilities, he has been Vice President in charge of Research of the University of Nantes from 1987 to 1997, Chairman of the French Diabetes Guidelines Committee and he is Past President of the French Diabetes Society (ALFEDIAM).

Bernard Charbonnel has published more than 300 original and/or review scientific papers, including recently The Lancet, Diabetes Care, Diabetologia, Diabetic Medicine, The Journal of American College of Cardiology, The Journal of Endocrinology & Metabolism…. He was member of the Executive committee of the recently published PROactive Study.

His main current fields of interest are devoted to clinical research in Diabetes, mainly insulin therapy in Type 1 and Type 2 Diabetes, prevention of cardiovascular complications of Type 2 Diabetes, new treatments of Type 2 Diabetes and, more generally, the ways of optimizing the management of Type 2 Diabetes.